Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Temporal trends in outcome and patient characteristics in dilated cardiomyopathy, data from the Swedish Heart Failure Registry 2003–2015

Fig. 2

Risk of 1 year composite endpoint (death, heart transplantation, and any cause hospitalization) over calendar periods, and interaction with time, adjusted for age and sex. HR indicates hazard ratio, NYHA New York Heart Association functional class, LVEF left ventricular ejection fraction, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blockade, MRA mineralocorticoid receptor antagonist

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us